News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Ulrik Lassen, MD, PhD

Articles by Ulrik Lassen, MD, PhD

Diagnosis and Management of TRK Fusion Cancer

ByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MD

January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

ByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPh

January 11th 2022

Latest Updated Articles

Diagnosis and Management of TRK Fusion Cancer
Published: January 11th 2022 | Updated:
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
Published: January 11th 2022 | Updated:

Trending on AJMC

FDA Approves Inebilizumab for Generalized Myasthenia Gravis

Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia

Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD

Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis

5 Key Oncology FDA Approvals From November

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.